Recent Updates
Recently added Catalysts
ADMA Negative Sentiment Score: 25/100

ADMA Biologics Investor News: If You Have Suffered Losses in ADMA Biologics, Inc. (NASDAQ: ADMA), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

Key Takeaway: Rosen Law Firm is investigating potential securities claims on behalf of shareholders of ADMA Biologics, Inc. due to allegations of misleading information being issued by the company. This follows a report from a short seller that claimed ADMA engaged in channel stuffing to inflate its revenue, which led to a significant drop in the stock price by 16.6%. Investors who suffered losses may be eligible for compensation through a class action lawsuit that the firm is preparing. The law firm emphasizes the importance of selecting counsel with relevant experience.

Market Sentiment Analysis

CONCERNS & RISKS

  • Allegations of materially misleading business information from ADMA Biologics.
  • ADMA shares fell 16.6% following short seller claims about revenue inflation.
  • Investors are encouraged to join a class action due to potential securities claims.

Full Press Release Details

NEW YORK, April 21, 2026 (GLOBE NEWSWIRE) --
WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of ADMA Biologics, Inc. (NASDAQ: ADMA) resulting from allegations that ADMA Biologics may have issued materially misleading business information to the investing public.
SO WHAT: If you purchased ADMA Biologics securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. The Rosen Law Firm is preparing a class action seeking recovery of investor losses.
WHAT TO DO NEXT: To join the prospective class action, go to https://rosenlegal.com/submit-form/?case_id=57940 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email case@rosenlegal.com for information on the class action.
WHAT IS THIS ABOUT: On March 24, 2026, Investing.com published an article entitled “ADMA Biologics shares plunge on short seller allegations.” The article stated that ADMA Biologics shares fell “after short seller Culper Research released a report alleging the company engaged in channel stuffing to inflate revenue growth.”
On this news, ADMA Biologics stock fell 16.6% on March 24, 2026.
WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved, at that time, the largest ever securities class action settlement against a Chinese Company. At the time Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.
Attorney Advertising. Prior results do not guarantee a similar outcome.
Contact Information:
Laurence Rosen, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
Toll Free: (866) 767-3653

Tags

Frequently Asked Questions

What is the investigation involving ADMA Biologics about?

Rosen Law Firm is investigating potential securities claims concerning ADMA Biologics for allegedly providing misleading business information.

How can I join the class action for ADMA Biologics?

To join, visit https://rosenlegal.com/submit-form/?case_id=57940 or call 866-767-3653.

What caused ADMA Biologics' stock to drop?

ADMA Biologics' stock fell 16.6% after allegations of channel stuffing were reported.

Why choose Rosen Law Firm for securities claims?

Rosen Law Firm is highly ranked and has successfully recovered substantial amounts for investors.

Are there any costs to join the class action?

No, if you purchased ADMA Biologics securities, there's no out-of-pocket fee to join.

Last updated: Apr 21, 2026